Competitive Inhibition

Competitive inhibition – sounds like a biochemistry lecture, and yes, it is. But this principle underpins many decisions your vet makes: in poisonings, with heart medications, in pain management. In short: two substances compete for the same docking site on an enzyme. Whoever wins determines what happens in the body.

Why should dog owners care?

Because your vet uses this mechanism almost daily – often without naming it. In poisonings, it can save lives. With medications, it explains why two preparations suddenly no longer work as planned. The basic principle: a medication displaces a toxin – or an endogenous substance – from its site of action. And the good thing about it? The process is reversible. If enough of the original substance is added, it can displace the inhibitor again.

How does this work concretely in dogs?

Imagine the enzyme as a lock that waits for only one specific key – the substrate. In competitive inhibition, a second key appears that looks damn similar, but only blocks the lock without opening it.

A practical example: If a dog has accidentally ingested methanol – for instance, from certain cleaning agents – it competes with ethanol for the same enzyme. Ethanol, as the “less harmful” competitor, occupies the binding site and thus slows down the activation of methanol into even more toxic breakdown products. This may sound paradoxical, but it is a genuine emergency mechanism.

Which dog medications work on this principle?

Painkillers from the NSAID group – i.e. non-steroidal anti-inflammatory drugs such as meloxicam or carprofen – inhibit the enzyme cyclooxygenase in exactly this way. They occupy the site where inflammation-promoting messengers are normally produced. No free space, no inflammatory reaction to that extent. That is why they have pain-relieving and anti-inflammatory effects.

The same applies to ACE inhibitors in heart disease. The enzyme that constricts blood vessels is blocked – blood pressure drops, relieving the heart. Many dogs with mitral valve disease are prescribed exactly this.

In which poisonings is this principle used?

The textbook example is fomepizole in antifreeze poisoning. Ethylene glycol – the actually dangerous substance in antifreeze – is normally converted by the enzyme alcohol dehydrogenase into highly toxic breakdown products. Fomepizole occupies this binding site first and prevents exactly that. Without this displacement, even small amounts of ethylene glycol can be fatal for dogs.

In some plant poisonings, vets also deliberately use substances that literally take the space away from the toxins – before any damage is done.

What makes competitive inhibition different from other forms of inhibition?

Here lies a crucial difference: Competitive inhibition can be overcome with more substrate. If your dog’s body no longer produces an essential substance sufficiently because a medication competitively inhibits it, a higher dose of the body’s own substance can break the blockade. This is therapeutically useful.

Different with non-competitive inhibition: There, the inhibitor attacks at a completely different site on the enzyme and changes its shape – permanently. More substrate then does not help. The enzyme simply no longer functions properly, regardless of how much is supplied.

When does competitive inhibition become a problem?

Drug interactions. That is the big issue. If two medications use the same metabolic pathway in the body – i.e. compete for the same enzyme – one of them can rise in the blood because it is not broken down quickly enough. What looks like a normal dose then acts like an overdose.

That is exactly why your vet asks about all the medications your dog receives – including feed supplements that seem harmless. Some of them measurably influence enzyme activities. This can weaken or unintentionally strengthen the effect of heart medications. Completeness in this list is not bureaucracy, but genuine patient protection.